IBRNvsRXL
iShares Neuroscience and Healthcare ETF against ProShares Ultra Health Care — the fee, the flows, the book, and a year head-to-head.
Head to head
| IBRN | RXL | |
|---|---|---|
| Expense ratio | 0.47% | 0.95% |
| Assets | $7864.21T | $97M |
| Net flow, 1 month | +$2M | — |
| Net flow, 1 year | +$2M | −$3M |
| Return, YTD | +24.7% | — |
| Return, 1 year | +57.5% | — |
| Avg daily volume | 3K | 16K |
| Holdings | 54 | 73 |
| Listed | Aug 23, 2022 | Jan 31, 2007 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS